I agree that this site is using cookies. You can find further informations here.
X
Ramió-Torrentà, L.
325  results:
Search for persons X
?
1

Documento de consenso de la Sociedad Española de Neurología..:

Meca-Lallana, J.E. ; Martínez Yélamos, S. ; Eichau, S....
Neurología.  39 (2024)  2 - p. 196-208 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Consensus statement of the Spanish Society of Neurology on ..:

Meca-Lallana, J.E. ; Martínez Yélamos, S. ; Eichau, S....
Neurología (English Edition).  39 (2024)  2 - p. 196-208 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Consensus statement on the use of alemtuzumab in daily clin..:

Meca-Lallana, J.E. ; Fernández-Prada, M. ; García Vázquez, E....
Neurología (English Edition).  37 (2022)  8 - p. 615-630 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Gadolinium-enhanced brain lesions in multiple sclerosis rel..:

Martín-Aguilar, L. ; Presas-Rodriguez, S. ; Rovira, À....
Neurología (English Edition).  37 (2022)  7 - p. 557-563 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Gadolinium-enhanced brain lesions in multiple sclerosis rel..:

Martín-Aguilar, L. ; Presas-Rodriguez, S. ; Rovira, À....
Neurología.  37 (2022)  7 - p. 557-563 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Consenso de expertos sobre el uso de alemtuzumab en la prác..:

Meca-Lallana, J.E. ; Fernández-Prada, M. ; García Vázquez, E....
Neurología.  37 (2022)  8 - p. 615-630 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Four-year safety and effectiveness data from patients with ..:

Meca-Lallana, J. E. ; Oreja-Guevara, C. ; Muñoz, D....
PLOS ONE.  16 (2021)  10 - p. e0258437 , 2021
Link: https://doi.org/10.1371/..
 
?
8

Direct costs of relapses in patients with relapsing-remitti..:

Casado, V. ; Bonaventura, I. ; Brieva, L....
Neurology Perspectives.  1 (2021)  3 - p. 160-169 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Obesity status and obesity-associated gut dysbiosis effects..:

Contreras-Rodriguez, O. ; Arnoriaga-Rodríguez, M. ; Miranda-Olivos, R....
International Journal of Obesity.  46 (2021)  1 - p. 30-38 , 2021
Link: https://doi.org/10.1038/..
 
?
10

PND22 Discover Study, First Analysis Specific for Secondary..:

Oreja-Guevara, C. ; Río Izquierdo, J. ; Ara Callizo, J.R....
Value in Health.  23 (2020)  - p. S625-S626 , 2020
Link: https://doi.org/10.1016/..
 
?
11

A guide to treating gait impairment with prolonged-release ..:

Ramió-Torrentà, L. ; Álvarez-Cermeño, J.C. ; Arroyo, R....
Neurología (English Edition).  33 (2018)  5 - p. 327-337 , 2018
Link: https://doi.org/10.1016/..
 
?
12

Long-term Efficacy and Safety of Teriflunomide: An Analysis..:

Freedman, M.S. ; Inshasi, J.S. ; Ramió-torrentà, L....
Multiple Sclerosis and Related Disorders.  26 (2018)  - p. 257 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Cognitive function in obese subjects:

Rodríguez, M.Arnoriaga ; Blasco, G. ; Coll, C....
Clinical Nutrition.  37 (2018)  - p. S262 , 2018
Link: https://doi.org/10.1016/..
 
?
14

Guía de tratamiento del deterioro de la marcha con fampridi..:

Ramió-Torrentà, L. ; Álvarez-Cermeño, J.C. ; Arroyo, R....
Neurología.  33 (2018)  5 - p. 327-337 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Neuroinflammation in obesity: circulating lipopolysaccharid..:

Moreno-Navarrete, J M ; Blasco, G ; Puig, J...
International Journal of Obesity.  41 (2017)  11 - p. 1627-1635 , 2017
Link: https://doi.org/10.1038/..
 
1-15